Search

Author/Creator Mitchell, T C

1. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. (31st January 2019)

Authors:
Hamid, O; Robert, C; Daud, A; Hodi, F S; Hwu, W J; Kefford, R; Wolchok, J D; Hersey, P; Joseph, R; Weber, J S; Dronca, R; Mitchell, T C; Patnaik, A; Zarour, H M; Joshua, A M; Zhao, Q; Jensen, E; Ahsan, S; Ibrahim, N; Ribas, A
Journal:
Annals of oncology
Issue:
Volume 30:Number 4(2019)
Page Start:
582
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma. (25th June 2018)

Authors:
Tetzlaff, M T; Messina, J L; Stein, J E; Xu, X; Amaria, R N; Blank, C U; van de Wiel, B A; Ferguson, P M; Rawson, R V; Ross, M I; Spillane, A J; Gershenwald, J E; Saw, R P M; van Akkooi, A C J; van Houdt, W J; Mitchell, T C; Menzies, A M; Long, G V; Wargo, J A; Davies, M A
Journal:
Annals of oncology
Issue:
Volume 29:Number 8(2018)
Page Start:
1861
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search